This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Inotek Pharmaceuticals Corporation

Drug Names(s): PJ-875, trabodenoson

Description: INO-8875 (formerly PJ-875) is a potent and highly selective activator of the adenosine 1 (A1) receptor. INO-8875 is thought to work by restoring trabecular meshwork outflow and may have a secondary mechanism of action of reducing aqueous humor production.

INO-8875 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug